Grants / Department of Health and Human Services / Centers for Disease Control and Prevention - ERA

RFA-PS-23-002: Enhancing Telehealth Strategies to Support Retention and Adherence to Antiretroviral Therapy (ART)

Closed Closed March 17, 2023 Opportunity RFA-PS-23-002 ☆ Save

This grant is closed. A newer notice from the same program is open now: NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) (PA-27-100). Status: Due dates in the notice, expires April 5, 2027. It is in our archive of Centers for Disease Control and Prevention - ERA notices from 2023.

• Award ceiling$450,000
• Award floor$350,000
• Total funding$3.6 million
• Expected awards2
• Cost sharingNot required
• Funding typeCooperative Agreement

Key dates

Who can apply

This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.

N/A

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses.

Is this a realistic fit?

• Past Prevention of Disease, Disability, and Death by Infectious Diseases awards averaged $1.9 million; this notice allows up to $450,000 per award.
• No cost sharing or match is required.

What the grant funds

The purpose of this Notice of Funding Opportunity (NOFO) is to support the evaluation of the effectiveness of an enhanced telehealth program to improve adherence to HIV prevention and treatment medication, while also exploring the “implementability” of its practice into routine care. Specifically, the awardee will, via a hybrid effectiveness-implementation research design: 1) evaluate the effectiveness of an enhanced telehealth program for maintenance of HIV medication adherence among clinically stable people with HIV (PWH) and pre-exposure prophylaxis (PrEP) medication adherence for those at risk of HIV infection; and 2) identify potential implementation facilitators and challenges by evaluating the delivery of these strategies. Furthermore, the recipient will evaluate the cost and cost-effectiveness of providing telehealth to patients on antiretroviral therapy (ART) or PrEP, and evaluate program enhancements that will include, but may be not limited to, multi-month prescription refills, biospecimen sample self-collection, and the use of specialized staff such as community health workers and patient navigators. This enhanced telehealth program will focus on those disproportionately affected by HIV or at risk for HIV infection, including cis-gender Black or African American (hereafter referred to as Black) women with HIV, transgender women. and gay, bisexual and other men who have sex with men (hereafter referred to as MSM).

Category: Health.

Applying now

This notice no longer takes applications. Apply under the newer notice, PA-27-100, which is open now.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.